Cognito Therapeutics
PrivateLast Round
Series C
Mar 5, 2026
Total Funding Raised
$419.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cognito Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series C round in March 2026.
Cognito Therapeutics is a digital health company that develops disease-modifying therapies aimed at treating neurodegenerative disorders by utilizing induced brain wave oscillations to reactivate the brain's immune system and reduce key Alzheimer's disease markers such as amyloid plaques and tau tangles.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cognito Therapeutics Comparables
Compare Cognito Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sinaptica Therapeutics | 81% | |
| NeuroEM Therapeutics | 81% | |
| Nuuron | 78% |
For institutional investors. Book with your work email.
Cognito Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 5, 2026 | ||||
| Series C | Apr 1, 2025 | ||||
| Series B | Jul 2, 2024 | ||||
| Series B Extension | Feb 1, 2024 | ||||
| Series B | Mar 22, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cognito Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Vintage Partners | Series C |
| IAG Capital Partners | Series B, Series C |
| Starbloom Capital | Series B, Series B Extension, Series C |
| FoundersX Ventures | Series B Extension, Series B |
| Morningside Ventures | Series B, Series C, Series A |
| WS Investment Company | Series B |
| Alzheimer's Drug Discovery Foundation | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Monthly visitors increased 50% MoM.
- Jul 1, 2026
Topline data from the HOPE pivotal study anticipated in summer 2026.
For institutional investors. Book with your work email.
Cognito Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cognito Therapeutics's valuation, stock price, and market status.
Is Cognito Therapeutics a public or private company?
Cognito Therapeutics is a private company.
What is the current stock price of Cognito Therapeutics?
Cognito Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cognito Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cognito Therapeutics worth (valuation)?
Valuation information for Cognito Therapeutics is not publicly available.
Can I buy Cognito Therapeutics stock?
Cognito Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cognito Therapeutics's last funding round?
Cognito Therapeutics's most recent funding round was Series C on March 5, 2026.
Who are the main investors in Cognito Therapeutics?
Key investors in Cognito Therapeutics include IAG Capital Partners, Starbloom Capital, FoundersX Ventures, Morningside Ventures.
Will Cognito Therapeutics IPO soon?
No public IPO plans have been announced for Cognito Therapeutics.
How can I track Cognito Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cognito Therapeutics's shares on secondary markets.